<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Risks and benefits of menopausal hormone therapy (MHT)</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Risks and benefits of menopausal hormone therapy (MHT)</h1>
<div class="graphic"><div class="figure"><div class="ttl">Risks and benefits of menopausal hormone therapy (MHT)</div><div class="cntnt"><img src="data:png;base64,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"/></div><div class="graphic_lgnd"><p>Updated summary of the effects of orally administered CEE alone or combined with MPA in females ages 50 to 59 years during intervention phase of WHI. One set of analyses examined the risks and benefits of these agents in females ages 50 to 59 years. This figure plots these data, which are expressed here as excess risks and benefits per 1000 females using MHT for 5 years. Because females deciding to use MHT are more likely to continue this for a period of years rather than 1 year, this figure is constructed according to that assumption. WHI studies were not powered for age-related subset analyses, and none of the data presented in the figure are statistically significant. Nonetheless, this figure represents the best estimates that are available at the present time and are likely more reliable than similar estimates based on observational studies as reported previously in The Endocrine Society Scientific Statement.</p>
    
    The HR (95% CI) values for the bars in the figure are listed here with reference to the alphabetical designations shown next to the bars: (a) HR 0.60 (0.35-1.04); (b) HR 1.34 (0.82-2.19); (c) HR 0.82 (0.50-1.34); (d) HR 1.21 (0.81-1.80); (e) HR 0.99 (0.53-1.85); (f) HR 1.51 (0.81-2.82); (g) HR 1.53 (0.63-3.75); (h) HR 2.05 (0.89-4.71); (i) HR 1.66 (0.76-3.67); (j) HR 3.01 (1.36-6.66); (k) HR 0.71 (0.30-1.67); (l) HR 0.79 (0.29-2.18); (m) HR 1.00 (ns-ns); (n) HR 1.12 (0.45-2.75); (o) HR 0.62 (0.30-1.29); (p) HR 0.90 (0.72-1.11); (q) HR 0.82 (0.68-1.00); (r) HR 5.01 (0.59-42.9); (s) HR 0.17 (0.02-1.45); (t) HR 0.70 (0.46-1.09); (u) HR 0.67 (0.43-1.04); (v) HR 0.83 (0.67-1.04); and (w) HR 0.85 (0.66-1.09).<sup>[1]</sup></div><div class="graphic_footnotes">CEE: conjugated equine estrogen; E: estrogen; E+P: estrogen-progestin; HR: hazard ratio; MHT: menopausal hormone therapy; MPA: medroxyprogesterone acetate; WHI: Women's Health Initiative.</div><div class="graphic_reference">Reference:
    <ol>
<li>Santen RJ, Stuenkel CA, Burger HG, Manson JE. Competency in menopause management: whither goest the internist? J Womens Health (Larchmt) 2014; 23:281.</li>
</ol>
<p class="extra_spacing_top">Republished with permission of The Endocrine Society, from: Stuenkel CA, Davis SR, Gompel A, et al. Treatment of Symptoms of the Menopause: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2015. Copyright © 2015; permission conveyed through Copyright Clearance Center, Inc.</p></div><div id="graphicVersion">Graphic 87938 Version 6.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
